Europe's largest insurer expects earnings growth to accelerate in the next three years driven by its property and casualty division and promised to return three quarters of its net profit to ...
RealSelf, the largest and most trusted online resource for people exploring cosmetic treatments and providers, today revealed ...
One particular healthcare stock has shown its ability to soar on good news -- and it's had plenty of it. This year the ...
Weight-loss drugs could be a boon for insurers, but it is too soon to tell whether the industry will be transformed, the head ...
Meds like Wegovy are all over the news. But are they right for you, especially if you’re older than the average user?
Prescriptions for weight-loss drugs surged in 2024 and were much more popular in some states, particularly those in the South ...
The demand for weight loss drugs, like Ozempic and Wegovy, has skyrocketed in the past few years despite the high cost and ...
Shares of chocolate maker Hershey Co. on Monday were on track for their biggest percentage gain since 2016, after Bloomberg reported that Oreo maker Mondelez International Inc. was exploring a ...
Experts are divided on the subject, however. While some suggest that even small doses of Ozempic could suppress appetite, there is little scientific data to support claims that microdosing leads to ...
What Are GLP-1s? Glucagon-like peptide-1 receptor agonists, also known as GLP-1 drugs, are a class of medications that mimic the action of ...
Zepbound outperformed Wegovy for weight loss in a new clinical trial funded by Eli Lilly & Co., Zepbound's maker.
In "Black Market Weight Loss," RTÉ Investigates goes undercover to examine how prescription-only weight loss medication is ...